Here we discuss the involvement of calmodulin in coupling calcium signals to the cellular circuitry that controls normal and abnormal cardiac growth, gene expression and function, and we consider ...

In vivo generation of transient FAPCAR T cells improves cardiac function after injury. CAR T therapy, a “living drug,” traditionally involves isolation and purification of T cells outside the ...

Despite improvements in CPR and rates of getting patients to the hospital, only about 10% of people ultimately survive after out-of-hospital cardiac arrest (OHCA), translating to about 300,000 ...

Cell therapy, involving adult stem cells from bone marrow, has been shown to reduce the risk of heart attack and stroke in severe heart failure patients, according to a new study.

Despite early promising cardiac stem cell studies conducted at academic medical centers nationally and internationally, researchers still have questions about how stem cells work in the body in order ...

Resolving the developmental mechanisms of cardiac microthrombosis of SARS-CoV-2 based on single-cell transcriptome analysis Peer-Reviewed Publication Science China Press ...

Researchers have developed an 'off-the-shelf' artificial cardiac patch that can deliver cardiac cell-derived healing factors directly to the site of heart attack injury.

New voltage-sensitive dyes that allow scientists to view and record cardiac action potentials from layers deep within the heart have been developed. It is hoped that the new dyes will help ...

CaMKII, or Calcium and calmodulin-dependent protein kinase II, is critical to cardiomyocytes, the muscle cells of the heart, where it maintains the balance of calcium.

He “practically invented the field of cardiac stem cell therapy when he first reported that cardiac cells were capable of regeneration,” Cardiobrief and MedPage Today wrote about him last year.